HiRO Acquires DeltaMed Solutions, Expands Across 10 Countries

02 July 2024 | Tuesday | News

Strategic Acquisition Enhances HiRO’s Global Clinical Research Capabilities, Strengthening Position as Leading CRO Since 2020
Image Source : Public Domain

Image Source : Public Domain

Harvest Integrated Research Organization (HiRO), a full-service, boutique global CRO, is excited to announce its latest strategic move with the successful acquisition of DeltaMed Solutions, an emerging CRO with a robust foothold in the US. The acquisition, advised by Evercore as financial advisor, marks HiRO's third CRO acquisition since its establishment in 2020.

Following the acquisitions of ANZ-based PharmaSols in 2021 and US-based Courante Oncology last year, HiRO's global expansion continues with the integration of DeltaMed Solutions. With its established footprint in the US, Ireland, Mainland China, TaiwanAustraliaNew ZealandJapanSouth KoreaMalaysia, and the Philippines, HiRO solidifies its position as a comprehensive provider of end-to-end clinical research solutions on a global scale.

DeltaMed Solutions, headquartered in New Jersey, boasts a team of highly skilled industry professionals with 15-30 years of expertise in serving large to mid-sized pharmaceutical and biotechs. The leadership team also brings a wealth of experience in FDA and EMEA submissions. DeltaMed Solutions is widely recognized for its extensive experience and flexible service models in data management, biostatistics, programming, RWE solutions, PK/PD analysis, regulatory and medical affairs. The company has earned recognition from clients and partners for its outstanding track record of excellence and service quality.

The full integration of DeltaMed Solutions into HiRO's operations will foster a powerful alliance, leveraging the expertise of both companies in key therapeutic areas and service offerings. This broadens HiRO's network of clients and partners, and enhances its ability to deliver capital-efficient, expedited, and customized clinical trial solutions, addressing the unmet R&D needs of pharmaceutical and biotech companies worldwide.

Dr. Karen Chu, Founder and CEO of HiRO, expressed her confidence in the acquisition, stating, "We are delighted to extend a warm welcome to DeltaMed Solutions. This acquisition aligns seamlessly with HiRO's growth strategy, enhancing our capability to continue delivering exceptional services that exceed industry standards. By combining our resources and expertise, we are strongly positioned to become our clients' trusted partner in advancing patient treatments and making a lasting impact on the healthcare landscape. This collaboration leverages our collective strengths, ensuring optimal efficiency and effectiveness in conducting clinical trials across a wide range of therapeutic areas in the US, Asia-Pacific, and beyond. This sets us apart as a pioneering force in the highly competitive CRO industry."

Dr. Sam Liang, President of DeltaMed Solutions, added, "We are thrilled to become an integral part of HiRO and contribute to their continued success. This opportunity allows us to harness our scientific expertise and well-established presence in the US. Working together, we will offer an enriched, globally integrated suite of services to our clients, driven by our shared dedication to quality, innovation, and patient-centric research. This collaboration will streamline processes and accelerate the development of groundbreaking treatments."

With this strategic acquisition, HiRO and DeltaMed Solutions join forces to provide an unparalleled range of services, delivering bespoke and efficient clinical trial solutions that effectively navigate market-specific complexities globally. Their shared vision and commitment to excellence in clinical research uniquely position them as key contributors to advancements in healthcare and pharmaceutical innovation.


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in